Michael F. Price’s Ginkgo Bioworks DNA Stock Holding History

Michael F. Price’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$202K	Buy	+1,250	New	+$243K	0.02%	109

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Michael F. Price's DNA Position: Q1 2022 in Review

Michael F. Price opened a new position in Ginkgo Bioworks (DNA) in Q1 2022: 1,250 shares worth $202K. The stake represents 0.02% of the portfolio and ranks #109 among its holdings.

190 funds tracked by Wall St. Rank hold DNA as of Q1 2022.

Michael F. Price held 1,250 shares of Ginkgo Bioworks worth $202K as of Q1 2022.
Ginkgo Bioworks was a new Michael F. Price position in Q1 2022.
Ginkgo Bioworks made up 0.02% of Michael F. Price's portfolio in Q1 2022, its #109 holding.
190 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2022.

Based on Michael F. Price's 13F filing for Q1 2022, filed 16 May 2022.